United States (US) Non-Small Cell Lung Cancer Diagnostics Market (2025-2031) | Companies, Trends, Analysis, Industry, Competitive Landscape, Forecast, Share, Value, Outlook, Size & Revenue, Segmentation, Growth

Market Forecast By Cancer Type (Lung Adenocarcinoma (LUAD), Lung Squamous Cell carcinoma (LUSC), Large Cell Carcinoma, Others), By Product (Reagents & Kits, Instruments And Services & Softwares), By Test (Imaging Test, Molecular Test, Biopsy, Sputum Cytology, Thoracentesis, Immunohistochemistry, Others), By End-User (Hospital, Clinical Laboratories, Academics, Others) And Competitive Landscape
Product Code: ETC9971599 Publication Date: Sep 2024 Updated Date: Jan 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Non-Small Cell Lung Cancer Diagnostics Market Outlook
  • Market Size of United States (US) Non-Small Cell Lung Cancer Diagnostics Market, 2024
  • Forecast of United States (US) Non-Small Cell Lung Cancer Diagnostics Market, 2031
  • Historical Data and Forecast of United States (US) Non-Small Cell Lung Cancer Diagnostics Revenues & Volume for the Period 2021- 2031
  • United States (US) Non-Small Cell Lung Cancer Diagnostics Market Trend Evolution
  • United States (US) Non-Small Cell Lung Cancer Diagnostics Market Drivers and Challenges
  • United States (US) Non-Small Cell Lung Cancer Diagnostics Price Trends
  • United States (US) Non-Small Cell Lung Cancer Diagnostics Porter's Five Forces
  • United States (US) Non-Small Cell Lung Cancer Diagnostics Industry Life Cycle
  • Historical Data and Forecast of United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Cancer Type for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Lung Adenocarcinoma (LUAD) for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Lung Squamous Cell carcinoma (LUSC) for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Large Cell Carcinoma for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Product for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Reagents & Kits for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Instruments And Services & Softwares for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Test for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Imaging Test for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Molecular Test for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Biopsy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Sputum Cytology for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Thoracentesis for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Immunohistochemistry for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By End-User for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Hospital for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Clinical Laboratories for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Academics for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Others for the Period 2021- 2031
  • United States (US) Non-Small Cell Lung Cancer Diagnostics Import Export Trade Statistics
  • Market Opportunity Assessment By Cancer Type
  • Market Opportunity Assessment By Product
  • Market Opportunity Assessment By Test
  • Market Opportunity Assessment By End-User
  • United States (US) Non-Small Cell Lung Cancer Diagnostics Top Companies Market Share
  • United States (US) Non-Small Cell Lung Cancer Diagnostics Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Non-Small Cell Lung Cancer Diagnostics Company Profiles
  • United States (US) Non-Small Cell Lung Cancer Diagnostics Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Non-Small Cell Lung Cancer Diagnostics Market - Industry Life Cycle

3.4 United States (US) Non-Small Cell Lung Cancer Diagnostics Market - Porter's Five Forces

3.5 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F

3.6 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F

3.7 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Test, 2021 & 2031F

3.8 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By End-User, 2021 & 2031F

4 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Trends

6 United States (US) Non-Small Cell Lung Cancer Diagnostics Market, By Types

6.1 United States (US) Non-Small Cell Lung Cancer Diagnostics Market, By Cancer Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Cancer Type, 2021- 2031F

6.1.3 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Lung Adenocarcinoma (LUAD), 2021- 2031F

6.1.4 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Lung Squamous Cell carcinoma (LUSC), 2021- 2031F

6.1.5 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Large Cell Carcinoma, 2021- 2031F

6.1.6 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Non-Small Cell Lung Cancer Diagnostics Market, By Product

6.2.1 Overview and Analysis

6.2.2 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Reagents & Kits, 2021- 2031F

6.2.3 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Instruments And Services & Softwares, 2021- 2031F

6.3 United States (US) Non-Small Cell Lung Cancer Diagnostics Market, By Test

6.3.1 Overview and Analysis

6.3.2 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Imaging Test, 2021- 2031F

6.3.3 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Molecular Test, 2021- 2031F

6.3.4 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Biopsy, 2021- 2031F

6.3.5 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Sputum Cytology, 2021- 2031F

6.3.6 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Thoracentesis, 2021- 2031F

6.3.7 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F

6.4 United States (US) Non-Small Cell Lung Cancer Diagnostics Market, By End-User

6.4.1 Overview and Analysis

6.4.2 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Hospital, 2021- 2031F

6.4.3 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Clinical Laboratories, 2021- 2031F

6.4.4 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Academics, 2021- 2031F

6.4.5 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Import-Export Trade Statistics

7.1 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Export to Major Countries

7.2 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Imports from Major Countries

8 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Key Performance Indicators

9 United States (US) Non-Small Cell Lung Cancer Diagnostics Market - Opportunity Assessment

9.1 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F

9.2 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F

9.3 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Test, 2021 & 2031F

9.4 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By End-User, 2021 & 2031F

10 United States (US) Non-Small Cell Lung Cancer Diagnostics Market - Competitive Landscape

10.1 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Revenue Share, By Companies, 2024

10.2 United States (US) Non-Small Cell Lung Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All